Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance
Description
CONCLUSIONS: Bempedoic acid was well-tolerated compared with placebo. Safety data from the long-term CLEAR Outcomes study reinforce the positive benefit-risk profile of bempedoic acid.
